Ron Yu
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- Statistical Methods in Clinical Trials 7
- Statistical Methods and Bayesian Inference 1
- Oncology 7
- HER2/EGFR in Cancer Research 5
- Cancer Cells and Metastasis 1
- Co-authors
- Tingjun Hou (1 shared paper)Antonio González-Martı́n (2 shared papers)Hans P. M. W. Wildiers (2 shared papers)Ian E. Krop (2 shared papers)Melanie C. Smitt (2 shared papers)Patricia Mucci LoRusso (3 shared papers)Jean-Marc Ferrero (1 shared paper)Sung‐Bae Kim (1 shared paper)
- Journals
- Contemporary Clinical Trials (4 papers)Blood (3 papers)Statistics in Medicine (2 papers)Journal of Medicinal Chemistry (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesSouth KoreaSpain
In The Last Decade
Ron Yu
26 papers receiving 2k citations
Ron Yu's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 665
- Cancer Research 203
- Computational Theory and Mathematics 215
- Genetics 99
- Molecular Biology 507
Countries citing papers authored by Ron Yu
This map shows the geographic impact of Ron Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Yu more than expected).
Fields of papers citing papers by Ron Yu
This network shows the impact of papers produced by Ron Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Yu. The network helps show where Ron Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ron Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2014 | 590 |
| 2 | 2007 | 245 | |
| 3 | 2012 | 211 | |
| 4 | 2010 | 193 | |
| 5 | 2005 | 126 | |
| 6 | 2004 | 90 | |
| 7 | 2016 | 86 | |
| 8 | 2014 | 81 | |
| 9 | 2006 | 77 | |
| 10 | 2014 | 75 | |
| 11 | 2005 | 68 | |
| 12 | 2014 | 66 | |
| 13 | 2005 | 54 | |
| 14 | 2016 | 28 | |
| 15 | 2022 | 18 | |
| 16 | 2012 | 14 | |
| 17 | 2006 | 12 | |
| 18 | 2013 | 11 | |
| 19 | 2008 | 8 | |
| 20 | 2013 | 6 |
About Ron Yu
Ron Yu is a scholar working on Statistics and Probability, Oncology, Hematology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 2.1k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (7 papers), HER2/EGFR in Cancer Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Cell death mechanisms and regulation (3 papers), Gastric Cancer Management and Outcomes (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Statistical Methods and Bayesian Inference (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (665 citations), Cancer Research (203 citations), Computational Theory and Mathematics (215 citations), Genetics (99 citations) and Molecular Biology (507 citations). Ron Yu has collaborated with scholars based in United States, South Korea and Spain. Frequent co-authors include Tingjun Hou, Antonio González-Martı́n, Hans P. M. W. Wildiers, Ian E. Krop, Melanie C. Smitt, Patricia Mucci LoRusso, Jean-Marc Ferrero, Sung‐Bae Kim, Abraham C.F. Leung and Branimir Ivan Sikic. Their work appears in journals such as Contemporary Clinical Trials, Blood, Statistics in Medicine, Journal of Medicinal Chemistry and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.